Insiders bought $3.0M of Inhibikase Therapeutics, Inc. in the last 12 months

1 insider bought on 1 day.

$3.0MBought, 12 mo

$0Sold, 12 mo

$230.2MMarket cap

IKT over the last year

Insider buy filed (1 day)

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

2 insider filings since 2021, newest first

Sands Capital Life Sciences Pulse Fund Ii, L.P. · 10% owner

Milton H. Werner · President, CEO and 10% owner

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.